Transpek Industry accepts R&D head resignation effective July 15

1 min read     Updated on 13 Jul 2026, 06:13 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Transpek Industry Limited has accepted the resignation of Dr. Gurpreet Kaur, Senior General Manager (R&D and QC), effective July 15, 2026, due to professional circumstances. The disclosure was made to BSE under Regulation 30 of SEBI LODR Regulations. The company confirmed the relieving date and noted that the resignation letter is attached to the filing.

powered bylight_fuzz_icon
45492198

*this image is generated using AI for illustrative purposes only.

Transpek Industry Limited has accepted the resignation of Dr. Gurpreet Kaur from the position of Senior General Manager (R&D and QC), effective July 15, 2026. The resignation was tendered on July 13, 2026, citing professional circumstances, and the company confirmed she will be relieved from her duties at the close of business hours on the effective date. This development impacts the company's research and development leadership as it continues operations in the chemical sector.

The company submitted the intimation to BSE Limited pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was made to inform the stock exchange about the change in senior management personnel. The company confirmed that the resignation has been accepted and the necessary details have been provided as per the regulatory requirements.

Dr. Gurpreet Kaur, who was heading the R&D and QC departments, submitted her formal resignation letter to the Managing Director. In her communication, she requested to be relieved of her duties by July 15, 2026. The company acknowledged the request and processed the resignation in accordance with the stated timeline. The resignation letter is attached as Annexure B to the regulatory filing.

The following table outlines the key details of the resignation as disclosed under SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026:

Sr. No. Particulars Information
1 Name Dr. Gurpreet Kaur
Reason for change Resigned as Sr. General Manager (R&D and QC) due to professional circumstances.
2 Date of cessation Resignation w.e.f., closure of business hours on 15/07/2026.
3 Brief profile NA.
4 Disclosure of relationships Not Applicable
5 Letter of Resignation Attached as Annexure - B

The resignation was accepted by the company's human resources department. The acceptance was noted by Prashant Vaidya, Vice President (HR), on July 13, 2026. The company has ensured that all procedural formalities related to the exit of the senior management personnel have been completed. The information regarding the resignation is also available on the company's official website.

Historical Stock Returns for Transpek Industry

1 Day5 Days1 Month6 Months1 Year5 Years
-0.65%-4.42%-4.86%-14.39%-14.39%-14.39%

Who will be appointed to lead R&D and QC following Dr. Gurpreet Kaur's departure?

How will this leadership change impact Transpek Industry's ongoing research projects and innovation pipeline?

What specific 'professional circumstances' prompted the resignation, and could they signal broader issues within the company?

Transpek Industry receives Responsible Care logo for three years

0 min read     Updated on 08 Jul 2026, 01:11 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Transpek Industry Limited received the Responsible Care Logo certificate from the Indian Chemical Council, valid for three years from July 2026 to June 2029. This certification highlights the company's dedication to sustainability and safety within the chemical industry.

powered bylight_fuzz_icon
45041679

*this image is generated using AI for illustrative purposes only.

Transpek Industry Limited has secured the right to use the Responsible Care Logo for a three-year period starting July 2026, reinforcing its commitment to sustainability standards in the chemical sector. The certification, issued by the Indian Chemical Council, is valid until June 2029 and authorizes the company to display the logo as a mark of its adherence to responsible practices.

The Responsible Care initiative is a global voluntary effort aimed at improving the chemical industry's performance in health, safety, and environmental protection. By obtaining this certification, Transpek Industry aligns itself with these rigorous standards, which are monitored by the Indian Chemical Council.

The disclosure was made to BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The certificate confirms the company's eligibility to use the logo, signifying its compliance with the council's guidelines for sustainable chemical management.

Certification Detail Information
Initiative Name Responsible Care
Issuing Authority Indian Chemical Council
Validity Period July 2026 to June 2029
RC Logo No 084
ICC Membership No ICC-WR/RM/T-03

Historical Stock Returns for Transpek Industry

1 Day5 Days1 Month6 Months1 Year5 Years
-0.65%-4.42%-4.86%-14.39%-14.39%-14.39%

How might Transpek Industry's Responsible Care certification influence its ability to secure new contracts or partnerships with multinational chemical companies that prioritize ESG compliance?

Could this certification serve as a catalyst for Transpek Industry to expand its export footprint into markets with stringent environmental and safety regulations, such as the EU or North America?

How is Transpek Industry likely to leverage this certification to differentiate itself from competitors in the Indian chemical sector who may not hold similar sustainability credentials?

More News on Transpek Industry

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-14.39%